Your browser doesn't support javascript.
loading
RHD Genotypes in a Chinese Cohort of Pregnant Women.
Zhang, Jianjun; Zeng, Yan; Wang, Yuefeng; Fan, Jiaming; Chen, Haijiang; Yang, Dan; Shi, Xiaoliang; Xu, Hualin; Fu, Zimu; Sheng, Fang; Xuan, Jie; Pan, Xiaoxi; Zhang, Zhiming; Ai, Liping; Zhang, Yue; Pan, Jingjing; Zhao, Jing; Wang, Mingming.
Affiliation
  • Zhang J; Department of Blood Transfusion, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Zeng Y; Genetics Department, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Wang Y; Department of Blood Transfusion, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Fan J; Genetics Department, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Chen H; Department of Blood Transfusion, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Yang D; Department of Blood Transfusion, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Shi X; Department of Obstetrics and Gynecology, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Xu H; Department of Obstetrics and Gynecology, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Fu Z; Department of Gynecological Protection, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Sheng F; Department of Gynecological Protection, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Xuan J; Department of Gynecological Protection, Shaoxing Maternal and Child Health Hospital, Shaoxing, China.
  • Pan X; Tianjin Super Biotechnology Developing Co., Ltd., Tianjin, China.
  • Zhang Z; Tianjin Super Biotechnology Developing Co., Ltd., Tianjin, China.
  • Ai L; Tianjin Super Biotechnology Developing Co., Ltd., Tianjin, China.
  • Zhang Y; Tianjin Super Biotechnology Developing Co., Ltd., Tianjin, China.
  • Pan J; Zhejiang Biosan Biotechnology Co., Ltd., Hangzhou, China.
  • Zhao J; BGI Genomics, BGI-Shenzhen, Shenzhen, China.
  • Wang M; Zhejiang Biosan Biotechnology Co., Ltd., Hangzhou, China.
Front Genet ; 12: 752485, 2021.
Article de En | MEDLINE | ID: mdl-34970297
ABSTRACT
RHD variants in D¯ Chinese pregnant women arose difficulties in management during pregnancy. Therefore, this study aims to precisely manage D¯ pregnant women by evaluating the spectrum of RHD mutations in D¯ pregnant women and getting insight into the possible rare alleles of RHD. A total of 76 D¯ pregnant women were analyzed by performing polymerase chain reactions with sequence-specific primers (PCR-SSP), the 10 RHD exons Sanger sequencing, RHD zygosity detection, and mRNA sequencing (mRNA-seq). About 40% of alleles are variations of RHD, including RHD 1227A homozygous, RHD-CE(2-9)-D, et al. Therefore, we developed a molecular diagnostic strategy for Chinese women, and most D¯ pregnant women can be diagnosed with this simple decision tree. After RHD genotyping for D¯ pregnancy women, we eliminated at least 15% unnecessary ante- and postpartum injections of Rh immunoglobulin (RhIG). As the first pedigree study and the first functional analysis under physiological conditions, mRNA-seq revealed that c.336-1G>A mutation mainly led to the inclusion of the intron 2, which indirectly explained the D¯ phenotype in this family. We also developed a robust protocol for determining fetal RhD status from maternal plasma. All 31 fetuses were predicted as RhD positive and confirmed the RhD status after birth.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Risk_factors_studies Langue: En Journal: Front Genet Année: 2021 Type de document: Article Pays d'affiliation: Chine

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Guideline / Risk_factors_studies Langue: En Journal: Front Genet Année: 2021 Type de document: Article Pays d'affiliation: Chine